By Dominic Jones on September 21, 2006
By Dominic Jones AS A GROUP, big health care companies have the weakest overall performance when it comes to communicating with investors on the Web. The sector has the lowest average score out of the 10 sectors we track in our 134-point survey covering more than 525 of the world’s biggest companies. In the rankings [...]
Posted in Investor Relations Blog | Tagged Abbott Laboratories, Aetna Inc., Allergan Inc., Altana AG, Amgen Inc., AS A GROUP, AstraZeneca PLC, Baxter International Inc., Biogen Idec Inc, Biomet Inc., Biovail Corp., Boston Scientific Corp., Bristol Myers Squibb Co., business, Cardinal Health Inc., Celesio AG, Celgene Corp., communications, conference calls, Dickinson and Company, disclosure, earnings, Elan Corp., Eli Lilly and Co., Fisher Scientific International Inc., Forest Laboratories Inc., Fresenius Medical Care AG, Genentech Inc., Genzyme Corp., Germany, Gilead Sciences Inc., GlaxoSmithKline plc, HCA Inc., Humana Inc., IR websites, Johnson & Johnson, Kyphon Inc., management, McKesson Corp., MDS Inc., MedImmune Inc., Medtronic Inc., Merck & Co., Novartis AG, Novo Nordisk, Pfizer Inc., Quest Diagnostics Inc., Sanofi-Aventis, Schering-Plough Corporation, SEC, Shire plc, Smith & Nephew plc, St. Jude Medical, Teva Pharmaceutical Industries Ltd, thomson financial, transcripts, UCB Group, usability, WellPoint Inc., Wyeth, Zimmer Holdings Inc.
